Exelixis EXEL
NASDAQ EXEL
$58.94 -0.19 (-0.32%)
As of: Sep 4, 2026 · 3:18 PM EDT

Exelixis (EXEL) Interest Expenses (2010 - 2018)

Exelixis (EXEL) posted quarterly Interest Expenses of $2.0 million for Q2 2026, up 104.38% year-over-year from $958000.0 in Q2 2025, and up 5052.63% quarter-over-quarter from $38000.0 in Q1 2026.

Analysis

Exelixis (EXEL) Interest Expenses (2010 - 2018) Analysis & Trends

Exelixis' Interest Expenses history runs 17 years deep, the most recent figure standing at $2.0 million for Q2 2026.

  • In Q2 2026, Interest Expenses rose 104.38% year-over-year to $2.0 million; the TTM figure through Apr 2026 stood at $2.0 million (up 104.38% YoY), while the FY2026 annual figure was $87.7 million, up 1.95% from the prior year.
  • Interest Expenses for Q2 2026 stood at $2.0 million, up from $38000.0 in the prior quarter.
  • The five-year high for Interest Expenses was $86.0 million in Q1 2025, with the low at $38000.0 in Q1 2026.
  • The 5-year median for Interest Expenses is $8.5 million (2022), against an average of $21.1 million.
  • The sharpest annual moves came in 2022 and 2026: Interest Expenses jumped 17481.1% in 2022, then sank 99.96% in 2026.
  • Exelixis' Interest Expenses stood at $77.2 million in 2022, then gained by 7.47% to $83.0 million in 2023, then plunged by 98.62% to $1.1 million in 2024, then plunged by 93.3% to $77000.0 in 2025, then surged by 2442.86% to $2.0 million in 2026.
  • Business Quant data shows EXEL's Interest Expenses at $2.0 million in Q2 2026, $38000.0 in Q1 2026, and $77000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn -
5 Revolution Medicines 43.98 Bn 43.98 Bn - 23.78 Mn
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 93.62 Mn
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn 20.27 Mn
10 Exelixis 14.78 Bn 13.94 Bn 608.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 28, 2018 -1,000.00
Sep 28, 2018 1,000.00
Jun 30, 2017 4.26 Mn
Mar 31, 2017 4.42 Mn
Dec 30, 2016 4.49 Mn
Sep 30, 2016 7.83 Mn
Jun 30, 2016 10.45 Mn
Mar 31, 2016 10.29 Mn
Sep 30, 2015 10.04 Mn
Jun 30, 2015 11.96 Mn
Mar 31, 2015 12.40 Mn
Dec 31, 2014 5.24 Mn
Sep 30, 2014 12.28 Mn
Jun 30, 2014 12.08 Mn
Mar 31, 2014 11.76 Mn
Dec 31, 2013 5.05 Mn
Sep 30, 2013 11.43 Mn
Jun 30, 2013 11.24 Mn
Mar 31, 2013 11.06 Mn
Dec 31, 2012 9.00 Mn